GenDx has signed a global reseller agreement with Thermo Fisher Scientific assigning GenDx as a nonexclusive reseller of Applied Biosystems™ QuantStudio™ real-time PCR systems, including the QuantStudio 5, QuantStudio 6 Flex, and QuantStudio 7 Flex. Under the agreement, local distributors of GenDx are authorized to supply the above-mentioned QuantStudio systems and service contracts in their […]
Real-Time PCR workflow gains AOAC-RI approval for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England — Poultry and pork producers can now rapidly screen for 3 Salmonella targets with one rapid PCR test. The new Thermo Scientific RapidFinder Salmonella Multiplex PCR System is the first validated multiplex PCR assay for simultaneous detection […]
The FDA-approved, next-generation sequencing-based companion diagnostic rapidly identifies non-small cell lung cancer patients eligible for targeted therapies Ft. Myers, Florida –NeoGenomics, Inc. (NASDAQ: NEO), ), a leading global specialty oncology testing laboratory, has signed an agreement with Thermo Fisher Scientific to join the Next-Generation Sequencing Companion Dx Center of Excellence Program (COEP). NeoGenomics is one of […]
CAMBRIDGE, England CS Genetics Limited, a developer of tools and techniques for genomics, was granted its first patent (GB 2,539,675 B) on 22 November 2017. CS Genetics is developing Coding Strand Sequencing™: a platform for instrument-free, solution-phase indexing of nucleic acids. Coding Strand Sequencing™ uses a new class of macromolecular indexing tool called Coding Strands™ to tag […]
PLEASANTON, Calif. — Purigen Biosystems, Inc., a company providing next generation technology for extracting, enriching and quantifying nucleic acid from biological samples, today announced that Barney Saunders, PhD, has been appointed Chief Executive Officer and a member of the Board of Directors. Dr. Saunders brings 30 years of experience managing emergent technologies and commercializing disruptive products for life […]
Location: Cambridge Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in gene editing and […]
SAN DIEGO, CA and CAMBRIDGE, MA — Edico Genome and Seven Bridges today announced the availability of Edico Genome’s DRAGENTM pipelines within Seven Bridges’ cloud-based data ecosystem. Edico Genome’s DRAGEN Germline V2, DRAGEN Somatic V2 and DRAGEN RNA Gene Fusion Detection Pipelines are now live on the Seven Bridges platform, enabling customers to leverage DRAGEN’s ultra rapid speeds and accuracy. Seven Bridges […]
Location: Cambridge First-to-market cfDNA Reference Standard specific for EGFR gene mutations adds to Horizon’s existing portfolio of cfDNA controls Horizon’s EGFR Multiplex cfDNA Reference Standard allows laboratories to optimize, validate and routinely monitor performance of PCR-based tests, NGS, and other novel assays Covers EGFR mutations implicated in the responsiveness to EGFR tyrosine kinase inhibitors and […]
Our distributor agreement with BIOZOL expands the availability of the Novallele™ genotyping and copy number assays MELVILLE, N.Y. Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a new distributor, BIOZOL Diagnostica Vertrieb GmbH, that will distribute all of the Novallele […]
Base4 is celebrating the grant of DNA sequencing patent US 9,771,615. This is our 8th granted patent family and our 25th granted patent, 22 of which have been granted over the past 3 years. Base4 is an IP rich company and our continued success underlines the degree to which our approach is novel and highly […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
